Advertisement

Topics

Chiron Vaccines Company Profile

06:56 EDT 19th June 2018 | BioPortfolio

Nil

Contact

Phone: 06421-39 34 56
Fax: 06421-39 23 36
Email: presseanfragen@chiron.com


News Articles [419 Associated News Articles listed on BioPortfolio]

Cancer Vaccines May Overhaul Cancer Therapy in the Next Decade

The term “silver bullet” gets tossed around a lot, but cancer vaccines are just that. Unlike the flu vaccines that we’re familiar with, cancer vaccines are slightly different in that they don’...

Researchers report technical advances in production of HIV vaccines

Research on HIV over the past decade has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few candidate vaccines have been tested in clinical trials.

Big improvements in HIV vaccine production

Research on HIV has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few candidate vaccines have been tested in clinical trials. One reason is the technical di...

Scientists report big improvements in HIV vaccine production

(University of California - Santa Cruz) Research on HIV has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few candidate vaccines have been tested in clinica...

Study suggests way to improve flu vaccines

Current flu vaccines mainly target the virus surface protein hemagglutinin. A study suggests that vaccines designed to target neuraminidase might be more effective.

New VaxArray potency test kit for pandemic flu vaccines

(InDevR, Inc.) InDevR has expanded its VaxArray® product portfolio with a new reagent kit to address the 'need for speed' in combating flu viruses with pandemic potential. The VaxArray Influenza Pan...

Online information on vaccines and autism not always reliable

Google search results in several countries can provide unreliable information based on old, 'weak' scientific studies. Researchers analyzing the top 200 websites in a search for 'vaccines autism' foun...

CureVac to Pursue mRNA Vaccines Against Flu and Malaria

CureVac AG announced the awarding of two new grants from the Bill & Melinda Gates Foundation. The programs will leverage CureVac’s RNActive® prophylactic vaccine technology to develop mRNA-based va...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Methylene blue [General Injectables & Vaccines, Inc.]

METHYLENE BLUE 10MG/ML

Methylene blue [General Injectables & Vaccines, Inc]

Methylene Blue 10 mg/mL Injection, USP 10 mL Single Dose Vial

Arzerra [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA.ARZERRA (ofatumumab)Injection, for intravenous infusionIn...

Arzerra [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. ARZERRA (ofatumumab)Injection, for intravenous infusion...

PubMed Articles [472 Associated PubMed Articles listed on BioPortfolio]

Cell culture-derived flu vaccine: Present and future.

The benefit of influenza vaccines is difficult to estimate due to the complexity of accurately assessing the burden of influenza. To improve the efficacy of influenza vaccines, vaccine manufacturers h...

Cancer vaccines: translation from mice to human clinical trials.

Therapeutic cancer vaccines have been a long-sought approach to harness the exquisite specificity of the immune system to treat cancer, but until recently have not had much success as single agents in...

Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.

Vaccination with conjugated meningococcal vaccines is the best way to prevent invasive meningococcal disease. Changes in serogroup epidemiology have led to the inclusion of quadrivalent vaccines in th...

Lack of impact of rotavirus vaccines on seizure-related hospitalizations in children under 5 years old in Spain.

Up to date the impact of rotavirus (RV) vaccines on seizures has been poorly evaluated, with some studies but not all, showing different degrees of protection.

Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective.

Vaccination against influenza is the most effective approach for reducing influenza morbidity and mortality. However, influenza vaccines are unique among all licensed vaccines as they are updated and ...

Clinical Trials [980 Associated Clinical Trials listed on BioPortfolio]

Meningococcal B Vaccination in University Students

This study is the third in a series using the MenB vaccine from the National Institute of Public Health in Norway (NIPH). The vaccine was first made in response to a high incidence of dise...

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

To evaluate the safety and tolerability of the Chiron vaccine human immunodeficiency virus (HIV) p24(25 or 50 micrograms)/MF59 in healthy HIV-1 seronegative adults. To evaluate the immunog...

A Study to Test the Safety of Three Experimental HIV Vaccines

The purpose of this study is to test three experimental HIV vaccines. This study will look at whether it is safe to give these vaccines together and how the immune system responds to the ...

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

To evaluate the safety and immunogenicity of SF-2 rgp120 vaccine in MF59 versus MN rgp120 vaccine in alum in volunteers who are seronegative for HIV-1. AS PER AMENDMENT 07/02/97: To determ...

H5 Adult - Chiron Study of Bird Flu Vaccine

This study is will gather critical information on the safety, tolerability, and the immunogenicity (capability of causing an immune response) of A/H5N1 (Bird flu) virus vaccine in healthy ...

Companies [364 Associated Companies listed on BioPortfolio]

Chiron

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a dif...

Chiron Vision

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a dif...

Chiron Vaccines

Nil

Chiron Corporation - UK

Chiron's diversified business model provides multiple revenue streams to balance risk, fund innovation and promote growth. Our strategic focus on cancer and infectious disease supports three product p...

Chiron Corporation

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a dif...

More Information about "Chiron Vaccines" on BioPortfolio

We have published hundreds of Chiron Vaccines news stories on BioPortfolio along with dozens of Chiron Vaccines Clinical Trials and PubMed Articles about Chiron Vaccines for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chiron Vaccines Companies in our database. You can also find out about relevant Chiron Vaccines Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record